EP
VERA icon

Eversept Partners’s Vera Therapeutics VERA Stock Holding History

Eversept Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.9M Buy
2,212,770
+39,484
+2% +$1.47M 4.93% 5
2026
Q1 		$87.4M Sell
2,173,286
-899,018
-29% -$38.7M 4.61% 5
2025
Q4 		$156M Buy
3,072,304
+264,468
+9% +$9.39M 7.84% 1
2025
Q3 		$81.6M Buy
2,807,836
+424,781
+18% +$9.82M 5.62% 5
2025
Q2 		$56.1M Buy
2,383,055
+484,251
+26% +$10.9M 5.16% 4
2025
Q1 		$45.6M Buy
1,898,804
+298,789
+19% +$9.6M 4.63% 6
2024
Q4 		$67.7M Sell
1,600,015
-450,142
-22% -$19.9M 6.01% 4
2024
Q3 		$90.6M Buy
2,050,157
+6,943
+0.3% +$263K 6.21% 4
2024
Q2 		$73.9M Buy
2,043,214
+219,433
+12% +$8.7M 5.06% 8
2024
Q1 		$78.6M Sell
1,823,781
-91,049
-5% -$3.24M 5.25% 6
2023
Q4 		$29.5M Buy
1,914,830
+436,341
+30% +$5.54M 2.59% 14
2023
Q3 		$20.3M Sell
1,478,489
-262,462
-15% -$4.5M 1.72% 16
2023
Q2 		$27.9M Sell
1,740,951
-47,578
-3% -$430K 2.34% 11
2023
Q1 		$13.9M Buy
1,788,529
+1,377,221
+335% +$10.6M 0.97% 23
2022
Q4 		$7.96M Buy
411,308
+255,179
+163% +$4.62M 0.7% 33
2022
Q3 		$3.33M Buy
+156,129
New +$2.92M 0.29% 43

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Eversept Partners's VERA Position: Q2 2026 in Review

Eversept Partners increased its Vera Therapeutics (VERA) stake by 1.8% in Q2 2026, buying an estimated $1.47M and bringing the position to 2,212,770 shares worth $94.9M. The position accounts for 4.93% of the portfolio, ranked #5.

Eversept Partners first reported a position in VERA in Q3 2022 and has held it in 16 quarters since. The position peaked at $156M in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Eversept Partners held 2,212,770 shares of Vera Therapeutics worth $94.9M as of Q2 2026.
  • Eversept Partners bought 39,484 Vera Therapeutics shares in Q2 2026, an estimated $1.47M.
  • Vera Therapeutics made up 4.93% of Eversept Partners's portfolio in Q2 2026, its #5 holding.
  • Eversept Partners first reported a position in Vera Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Eversept Partners's Vera Therapeutics position peaked at $156M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.